NADPH oxidase and nitric oxide synthase-dependent superoxide production is increased in proliferative lupus nephritis

J. C. Oates, A. K. Mashmoushi, S. R. Shaftman, G. S. Gilkeson

Research output: Contribution to journalArticlepeer-review

9 Scopus citations

Abstract

Objective: Lupus nephritis (LN) is an immune complex-mediated glomerulonephritis. Proliferative LN (PLN, ISN/RPS classes III and IV)) often leads to renal injury or failure despite traditional induction and maintenance therapy. Successful targeted therapeutic development requires insight into mediators of inflammation in PLN. Superoxide (SO) and its metabolites are mediators of the innate immune response through their ability to mediate reduction-oxidation signaling. Endothelial nitric oxide synthase (eNOS) modulates inflammatory responses in endothelial cells. We hypothesized that markers of SO production would be increased in active PLN and that SO production would be dependent on the activity of select enzymes in the renal cortex. Methods: Patients with systemic lupus erythematosus were enrolled at the time of renal biopsy for active LN of all classes. Serum collected at baseline was analyzed by HPLC with electrochemical detection for markers of SO production (durable modifications of serum protein Tyr ultimately requiring SO as a substrate). Renal cortex from MRL/MpJ-FASlpr (MRL/lpr) mice with and without functional eNOS was analyzed during active disease for superoxide (SO) production with and without inhibitors of SO-producing enzymes. Results: Serum protein modifications indicative of total SO production were significantly higher in patients with PLN. These markers were increased in association with more active, inflammatory PLN. Mice lacking functional eNOS had 80% higher levels of renal cortical SO during active disease, and inhibitors of nitric oxide synthase and NADPH oxidase reduced these levels by 60% and 77%, respectively. Conclusion: These studies demonstrate that SO production is unique to active PLN in a NOS and NADPH oxidase-dependent fashion. These findings suggest the emulating or augmenting eNOS activity or inhibiting NADPH oxidase SO production may be targets of therapy in patients with PLN. The markers of SO production used in this study could rationally be used to select SO-modulating therapies and serve as pharmacodynamic indicators for dose titration.

Original languageEnglish (US)
Pages (from-to)1361-1370
Number of pages10
JournalLupus
Volume22
Issue number13
DOIs
StatePublished - Nov 2013
Externally publishedYes

Keywords

  • endothelial nitric oxide synthase
  • inflammation
  • Lupus nephritis
  • NADPH oxidase
  • nitric oxide
  • oxidation-reduction
  • proliferative lupus nephritis
  • superoxide
  • systemic lupus erythematosus

ASJC Scopus subject areas

  • Rheumatology

Fingerprint

Dive into the research topics of 'NADPH oxidase and nitric oxide synthase-dependent superoxide production is increased in proliferative lupus nephritis'. Together they form a unique fingerprint.

Cite this